{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:46:42Z","timestamp":1792424802978,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T00:00:00Z","timestamp":1455580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T00:00:00Z","timestamp":1455580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/tpj.2015.99","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T15:27:13Z","timestamp":1455636433000},"page":"174-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A pharmacogenomic study on the pharmacokinetics of tacrolimus in healthy subjects using the DMETTM Plus platform"],"prefix":"10.1038","volume":"17","author":[{"given":"Y","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J H","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,16]]},"reference":[{"key":"BFtpj201599_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40262-013-0120-3","volume":"53","author":"DA Hesselink","year":"2014","unstructured":"Hesselink DA, Bouamar R, Elens L, van Schaik RH, van Gelder T . The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. Clin Pharmacokinet 2014; 53: 123\u2013139.","journal-title":"Clin Pharmacokinet"},{"key":"BFtpj201599_CR2","unstructured":"Food and Drug Administration (US). Draft Guidance on Tacrolimus [Internet]. 2014 [updated 2014; cited 1 June 2015]. Available from http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm406344.pdf."},{"key":"BFtpj201599_CR3","unstructured":"The Phamarcogenomics Knowledgebase (US). Tacrolimus_PGx research [Internet]. [updated 2015; cited 1 Jun 2015]. Available from https:\/\/www.pharmgkb.org\/drug\/PA451578#tabview=tab1&subtab=31."},{"key":"BFtpj201599_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/cpt.113","volume":"98","author":"KA Birdwell","year":"2015","unstructured":"Birdwell KA, Decker B, Barbarino JM, Peterson JF, Stein CM, Sadee W et al. Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing. Clin Pharmacol Ther 2015; 98: 19\u201324.","journal-title":"Clin Pharmacol Ther"},{"key":"BFtpj201599_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrg796","volume":"3","author":"HK Tabor","year":"2002","unstructured":"Tabor HK, Risch NJ, Myers RM . Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002; 3: 391\u2013397.","journal-title":"Nat Rev Genet"},{"key":"BFtpj201599_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrg1521","volume":"6","author":"JN Hirschhorn","year":"2005","unstructured":"Hirschhorn JN, Daly MJ . Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005; 6: 95\u2013108.","journal-title":"Nat Rev Genet"},{"key":"BFtpj201599_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/FPC.0000000000000075","volume":"24","author":"S Yi","year":"2014","unstructured":"Yi S, An H, Lee H, Lee S, Ieiri I, Lee Y et al. Korean, Japanese, and Chinese populations featured similar genes encoding drug-metabolizing enzymes and transporters: a DMET Plus microarray assessment. Pharmacogenet Genomics 2014; 24: 477\u2013485.","journal-title":"Pharmacogenet Genomics"},{"key":"BFtpj201599_CR8","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.nano.2014.04.003","volume":"10","author":"S Gaur","year":"2014","unstructured":"Gaur S, Wang Y, Kretzner L, Chen L, Yen T, Wu X et al. Pharmacodynamic and pharmacogenomic study of the nanoparticle conjugate of camptothecin CRLX101 for the treatment of cancer. Nanomedicine 2014; 10: 1477\u20131486.","journal-title":"Nanomedicine"},{"key":"BFtpj201599_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/FPC.0b013e32834e1641","volume":"22","author":"KA Birdwell","year":"2012","unstructured":"Birdwell KA, Grady B, Choi L, Xu H, Bian A, Denny JC et al. The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients. Pharmacogenet Genomics 2012; 22: 32\u201342.","journal-title":"Pharmacogenet Genomics"},{"key":"BFtpj201599_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/clpt.2013.178","volume":"94","author":"MJ Ratain","year":"2013","unstructured":"Ratain MJ, Cox NJ, Henderson TO . Challenges in interpreting the evidence for genetic predictors of ototoxicity. Clin Pharmacol Ther 2013; 94: 631\u2013635.","journal-title":"Clin Pharmacol Ther"},{"key":"BFtpj201599_CR11","unstructured":"The Cocrane Collaberation (UK). Controlling for Confounding [Internet]. [updated on 2011; cited on 1 June 2015]. Available from http:\/\/handbook.cochrane.org\/chapter_13\/13_6_2_1_controlling_for_confounding.htm."},{"key":"BFtpj201599_CR12","doi-asserted-by":"crossref","unstructured":"Zhou H, Alexander DH, Sehl ME, Sinsheimer JS, Sobel EM, Lange K . Penalized regression for genome-wide association screening of sequence data. Pac Symp Biocomput 2011: 106\u2013117.","DOI":"10.1142\/9789814335058_0012"},{"key":"BFtpj201599_CR13","doi-asserted-by":"publisher","first-page":"e1002822","DOI":"10.1371\/journal.pcbi.1002822","volume":"8","author":"WS Bush","year":"2012","unstructured":"Bush WS, Moore JH . Chapter 11: Genome-wide association studies. PLoS Comput Biol 2012; 8: e1002822.","journal-title":"PLoS Comput Biol"},{"key":"BFtpj201599_CR14","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1098\/rsta.2009.0164","volume":"367","author":"PJ Bickel","year":"2009","unstructured":"Bickel PJ, Brown JB, Huang H, Li Q . An overview of recent developments in genomics and associated statistical methods. Philos Trans A Math Phys Eng Sci 2009; 367: 4313\u20134337.","journal-title":"Philos Trans A Math Phys Eng Sci"},{"key":"BFtpj201599_CR15","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/bioinformatics\/btp041","volume":"25","author":"TT Wu","year":"2009","unstructured":"Wu TT, Chen YF, Hastie T, Sobel E, Lange K . Genome-wide association analysis by lasso penalized logistic regression. Bioinformatics 2009; 25: 714\u2013721.","journal-title":"Bioinformatics"},{"key":"BFtpj201599_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/tpj.2013.11","volume":"14","author":"S Aslibekyan","year":"2014","unstructured":"Aslibekyan S, Brown EE, Reynolds RJ, Redden DT, Morgan S, Baggott JE et al. Genetic variants associated with methotrexate efficacy and toxicity in early rheumatoid arthritis: results from the treatment of early aggressive rheumatoid arthritis trial. Pharmacogenomics J 2014; 14: 48\u201353.","journal-title":"Pharmacogenomics J"},{"key":"BFtpj201599_CR17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R . Regression shrinkage and selection via the Lasso. J R Stat Soc B Methodol 1996; 58: 267\u2013288.","journal-title":"J R Stat Soc B Methodol"},{"key":"BFtpj201599_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jchromb.2004.02.002","volume":"805","author":"NV Ramakrishna","year":"2004","unstructured":"Ramakrishna NV, Vishwottam KN, Puran S, Manoj S, Santosh M, Wishu S et al. Liquid chromatography-negative ion electrospray tandem mass spectrometry method for the quantification of tacrolimus in human plasma and its bioanalytical applications. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 805: 13\u201320.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"BFtpj201599_CR19","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/hep.23549","volume":"51","author":"E Andrews","year":"2010","unstructured":"Andrews E, Armstrong M, Tugwood J, Swan D, Glaves P, Pirmohamed M et al. A role for the pregnane X receptor in flucloxacillin-induced liver injury. Hepatology 2010; 51: 1656\u20131664.","journal-title":"Hepatology"},{"key":"BFtpj201599_CR20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y . Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc B Methodol 1995; 57: 289\u2013300.","journal-title":"J R Stat Soc B Methodol"},{"key":"BFtpj201599_CR21","unstructured":"Clinical Annotation for rs776746 and tacrolimus [Internet]. [Available from https:\/\/www.pharmgkb.org\/clinicalAnnotation\/981203719."},{"key":"BFtpj201599_CR22","doi-asserted-by":"publisher","first-page":"38379","DOI":"10.1074\/jbc.M404949200","volume":"279","author":"O Burk","year":"2004","unstructured":"Burk O, Koch I, Raucy J, Hustert E, Eichelbaum M, Brockmoller J et al. The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR). J Biol Chem 2004; 279: 38379\u201338385.","journal-title":"J Biol Chem"},{"key":"BFtpj201599_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1053\/j.gastro.2005.12.008","volume":"130","author":"MM Dring","year":"2006","unstructured":"Dring MM, Goulding CA, Trimble VI, Keegan D, Ryan AW, Brophy KM et al. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology 2006; 130: 341\u2013348, quiz 592.","journal-title":"Gastroenterology"},{"key":"BFtpj201599_CR24","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/ibd.20252","volume":"13","author":"A Martinez","year":"2007","unstructured":"Martinez A, Marquez A, Mendoza J, Taxonera C, Fernandez-Arquero M, Diaz-Rubio M et al. Role of the PXR gene locus in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13: 1484\u20131487.","journal-title":"Inflamm Bowel Dis"},{"key":"BFtpj201599_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1177\/0091270009348223","volume":"50","author":"S Fanta","year":"2010","unstructured":"Fanta S, Jonsson S, Karlsson MO, Niemi M, Holmberg C, Hoppu K et al. Long-term changes in cyclosporine pharmacokinetics after renal transplantation in children: evidence for saturable presystemic metabolism and effect of NR1I2 polymorphism. J Clin Pharmacol 2010; 50: 581\u2013597.","journal-title":"J Clin Pharmacol"},{"key":"BFtpj201599_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1124\/dmd.110.035246","volume":"39","author":"JY Chung","year":"2011","unstructured":"Chung JY, Cho JY, Lim HS, Kim JR, Yu KS, Lim KS et al. Effects of pregnane X receptor (NR1I2) and CYP2B6 genetic polymorphisms on the induction of bupropion hydroxylation by rifampin. Drug Metab Dispos 2011; 39: 92\u201397.","journal-title":"Drug Metab Dispos"},{"key":"BFtpj201599_CR27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2165\/11318080-000000000-00000","volume":"48","author":"K Benkali","year":"2009","unstructured":"Benkali K, Premaud A, Picard N, Rerolle JP, Toupance O, Hoizey G et al. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients. Clin Pharmacokinet 2009; 48: 805\u2013816.","journal-title":"Clin Pharmacokinet"},{"key":"BFtpj201599_CR28","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/TP.0b013e31826c3985","volume":"94","author":"KA Barraclough","year":"2012","unstructured":"Barraclough KA, Isbel NM, Lee KJ, Bergmann TK, Johnson DW, McWhinney BC et al. NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation. Transplantation 2012; 94: 1025\u20131032.","journal-title":"Transplantation"},{"key":"BFtpj201599_CR29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/FTD.0b013e31829f1ab8","volume":"36","author":"TK Bergmann","year":"2014","unstructured":"Bergmann TK, Hennig S, Barraclough KA, Isbel NM, Staatz CE . Population pharmacokinetics of tacrolimus in adult kidney transplant patients: impact of CYP3A5 genotype on starting dose. Ther Drug Monit 2014; 36: 62\u201370.","journal-title":"Ther Drug Monit"},{"key":"BFtpj201599_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/FTD.0000000000000142","volume":"37","author":"H Bruckmueller","year":"2015","unstructured":"Bruckmueller H, Werk AN, Renders L, Feldkamp T, Tepel M, Borst C et al. Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A Locus. Ther Drug Monit 2015; 37: 288\u2013295.","journal-title":"Ther Drug Monit"},{"key":"BFtpj201599_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1124\/dmd.107.016600","volume":"36","author":"J Lamba","year":"2008","unstructured":"Lamba J, Lamba V, Strom S, Venkataramanan R, Schuetz E . Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor\/NR1I2 and their association with CYP3A4 expression. Drug Metab Dispos 2008; 36: 169\u2013181.","journal-title":"Drug Metab Dispos"},{"key":"BFtpj201599_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/sj.tpj.6500347","volume":"6","author":"EE Thompson","year":"2006","unstructured":"Thompson EE, Kuttab-Boulos H, Yang L, Roe BA, Di Rienzo A . Sequence diversity and haplotype structure at the human CYP3A cluster. Pharmacogenomics J 2006; 6: 105\u2013114.","journal-title":"Pharmacogenomics J"},{"key":"BFtpj201599_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4310\/SII.2013.v6.n1.a10","volume":"6","author":"J Liu","year":"2013","unstructured":"Liu J, Wang K, Ma S, Huang J . Accounting for linkage disequilibrium in genome-wide association studies: A penalized regression method. Stat Interface 2013; 6: 99\u2013115.","journal-title":"Stat Interface"},{"key":"BFtpj201599_CR34","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2133\/dmpk.DMPK-12-RG-148","volume":"28","author":"XC Zuo","year":"2013","unstructured":"Zuo XC, Zhou YN, Zhang BK, Yang GP, Cheng ZN, Yuan H et al. Effect of CYP3A5*3 polymorphism on pharmacokinetic drug interaction between tacrolimus and amlodipine. Drug Metab Pharmacokinet 2013; 28: 398\u2013405.","journal-title":"Drug Metab Pharmacokinet"}],"updated-by":[{"DOI":"10.1038\/s41397-024-00354-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000}},{"DOI":"10.1038\/tpj.2016.85","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T00:00:00Z","timestamp":1481587200000}}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tpj201599.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201599","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201599.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T07:03:33Z","timestamp":1731913413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj201599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,16]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFtpj201599"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2015.99","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/tpj.2016.85","asserted-by":"object"}],"correction":[{"id-type":"doi","id":"10.1038\/s41397-024-00354-x","asserted-by":"object"}]},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,16]]},"assertion":[{"value":"7 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41397-024-00354-x","URL":"https:\/\/doi.org\/10.1038\/s41397-024-00354-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}